The Scientist

» FDA and developmental biology

Most Recent

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: All In Proportion

All In Proportion

By | March 2, 2013

Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.

0 Comments

image: Contributors

Contributors

By | March 1, 2013

Meet some of the people featured in the March 2013 issue of The Scientist.

0 Comments

image: Instant Messaging

Instant Messaging

By | March 1, 2013

During development, communication between organs determines their relative final size.

2 Comments

image: Robo-Eye to Enter US Market

Robo-Eye to Enter US Market

By | February 11, 2013

A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.

2 Comments

image: Stem-Cell Clinic Moves to Mexico

Stem-Cell Clinic Moves to Mexico

By | February 1, 2013

A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.  

0 Comments

image: Fellow Travelers

Fellow Travelers

By | February 1, 2013

Collective cell migration relies on a directional signal that comes from the moving cluster, rather than from external cues.

1 Comment

image: Go Forth, Cells

Go Forth, Cells

By | February 1, 2013

Watch the cell transplant experiments in zebrafish that suggest certain embryonic cells rely on intrinsic directional cues for collective migration.

0 Comments

image: Opinion: Regenerating Safely

Opinion: Regenerating Safely

By | January 21, 2013

Patient safety is paramount in regulating new stem cell treatments.

1 Comment

image: First Recombinant Flu Vaccine

First Recombinant Flu Vaccine

By | January 21, 2013

The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.

1 Comment

Popular Now

  1. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. Will Organs-in-a-Dish Ever Replace Animal Models?
  4. Your Office Has a Distinct Microbiome
RayBiotech